The FDA is expected to grant full approval of Pfizer's Covid-19 vaccine next week. The two-dose shot was first cleared in December by the agency on an emergency use basis.
The Food and Drug Administration is expected next week to grant full approval of the Covid-19 vaccine from Pfizer Inc. and partner BioNTech SE, according to people familiar with the planning, an action that could spur more vaccination requirements by employers and encourage more people who are hesitant to get vaccinated.
The two-dose shot was first cleared in December by the agency on an emergency use basis for people 16 years and older. The emergency designation allows for products to be distributed during public-health crises based on the best available evidence. Opponents of mandatory vaccinations have cited the emergency approval as grounds for not requiring inoculations, so full approval is expected to lead more businesses and institutions to require mandatory vaccinations.
Public health officials and vaccine experts also hope full approval will sway some people who have been hesitant to get vaccinated. About 60% of eligible people in the U.S. are fully vaccinated, according to federal figures. Three in 10 unvaccinated adults said they would be more likely to get vaccinated if one of the vaccines currently authorized for emergency use were to receive full approval from the FDA, according to a June poll by the Kaiser Family Foundation.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Full FDA approval of Pfizer/BioNTech Covid-19 vaccine is 'imminent, senior federal official saysJUST IN: Full FDA approval of the Pfizer/BioNTech Covid-19 vaccine is 'imminent,' a senior official says, and 'could be as early as Monday,' according to a Biden official
Weiterlesen »
As Covid-19 Boosters Loom, Pfizer and Moderna Expected to See Billions More in SalesVaccine makers Pfizer and Moderna are on track to notch billions more in sales than previously expected, as new booster-shot strategies and concerns about the Delta variant push demand, and the companies raise prices in the U.S. and elsewhere
Weiterlesen »
US FDA aims to give full nod to Pfizer’s Covid-19 vaccine – latest updatesUS FDA aims to give full nod to Pfizer’s Covid19 vaccine on Monday. Other updates: 🇧🇷 Brazil has 870 deaths in 24 hours 🇺🇸 US gives 500,000 vaccine doses to Kosovo 🇬🇧 Euro 2020 final at Wembley was a 'superspreader' event For more:
Weiterlesen »
Welcome! You are invited to join a meeting: Conversaciones Comunitarias de COVID-19 y la Vacuna de COVID-19 | Community Conversations about COVID-19 and the COVID-19 Vaccine. After registering, you will receive a confirmation email about joining the meeting.
Weiterlesen »
Texas health officials warn of full ICUs as state grapples with worsening Covid-19 surgeTexas health officials say the state is in 'one of its worst fights' as Covid-19 hospitalizations rise and leaders and local districts defy safety measures
Weiterlesen »